Four-dimensional computed tomography contouring variability in stereotactic body radiotherapy of non-resectable biliary tract cancer

Four-dimensional computed tomography contouring variability in stereotactic body radiotherapy of non-resectable biliary tract cancer

Bibliographic Details
Main Authors:	Robinson, M, Eaton, D, Holyoake, D, Hawkins, M
Format:	Journal article
Language:	English
Published:	Elsevier 2017

Similar Items

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
by: Holyoake, D, et al.
Published: (2016)

EP-1720: Impact of contouring variability on tumour control and normal tissue toxicity in liver SBRT
by: Robinson, M, et al.
Published: (2016)

SPARC: A phase-I trial of pre-operative margin-intensified stereotactic radiotherapy for pancreatic cancer at high risk of positive resection margins
by: Holyoake, D, et al.
Published: (2018)

Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancer
by: Wee Loon Ong, et al.
Published: (2024-03-01)

Stereotactic body radiotherapy for liver metastases.
by: Aitken, K, et al.
Published: (2015)

Stereotactic body radiotherapy for oligometastases.
by: Tree, A, et al.
Published: (2013)

Patient specific contouring region of interest for abdominal stereotactic adaptive radiotherapy
by: Alex T. Price, et al.
Published: (2023-01-01)

Feasibility of fast, four-dimensional computed tomography-based O-ring LINAC plans for lung stereotactic body radiotherapy in patients with poor performance status
by: Eun Jeong Heo, et al.
Published: (2023-11-01)

UK consensus on normal tissue dose constraints for stereotactic radiotherapy
by: Hanna, G, et al.
Published: (2017)

Developments in Stereotactic Body Radiotherapy
by: Anoop Haridass
Published: (2018-12-01)

Recent Advances and Challenges in Stereotactic Body Radiotherapy
by: Atsuto Katano MD, PhD, et al.
Published: (2024-02-01)

Impact of preoperative body compositions on survival following resection of biliary tract cancer
by: Seung Bae Yoon, et al.
Published: (2019-08-01)

Adjuvant treatment after resection of biliary-tract cancer: yes or no?
by: Eveline Boucher, et al.
Published: (2011-12-01)

Meta-analysis of toxicity and small-bowel radiotherapy dose-volume: “omnibus consequentia”
by: Holyoake, D, et al.
Published: (2018)

Stereotactic body radiotherapy plus cetuximab for previously irradiated un-resectable head and neck cancer
by: Tai-Lin Huang, et al.
Published: (2022-10-01)

CORE: A randomised trial of COnventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
by: Khoo, V, et al.
Published: (2017)

Stereotactic Radiotherapy for Oligometastasis
by: Sotaro Otake, et al.
Published: (2019-01-01)

CORE: A randomised trial of COventional care versus Radioablation (stereotactic body radiotherapy) for Extracranial oligometastases
by: Khoo, V, et al.
Published: (2017)

UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus
by: Hanna, G, et al.
Published: (2016)

Systematic review and meta-analysis of small bowel dose–volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy
by: Holyoake, D, et al.
Published: (2019)

A comprehensive quality assurance program for four-dimensional computed tomography in radiotherapy
by: Jinane Bakkali Tahiri, et al.
Published: (2023-07-01)

Application of four-dimensional cone beam computed tomography in lung cancer radiotherapy
by: Muyasha Abulimiti, et al.
Published: (2023-04-01)

Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
by: Tse, R, et al.
Published: (2008)

Variation in clinical target volume delineation in postoperative radiotherapy for biliary tract cancer.
by: Taeryool Koo, et al.
Published: (2022-01-01)

Editorial: Stereotactic body radiotherapy for lung cancer
by: An Liu, et al.
Published: (2023-04-01)

Editorial: Stereotactic body radiotherapy for prostate cancer
by: Amar U. Kishan, et al.
Published: (2022-10-01)

Role of pelvic CT during surveillance of patients with resected biliary tract cancer
by: Aslam, Anum, et al.
Published: (2022)

Role of pelvic CT during surveillance of patients with resected biliary tract cancer
by: Aslam, Anum, et al.
Published: (2021)

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
by: Holyoake, D, et al.
Published: (2017)

Stereotactic Radiotherapy for Renal Denervation
by: Mahfoud, Felix, et al.
Published: (2020)

Stereotactic Radiotherapy in Uveal Melanoma
by: Ela Delikgöz Soykut, et al.
Published: (2014-09-01)

A cardiac contouring atlas for radiotherapy
by: Duane, F, et al.
Published: (2017)

A cardiac contouring atlas for radiotherapy.
by: Duane, F, et al.
Published: (2017)

Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases
by: Sofian Benkhaled, et al.
Published: (2024-03-01)

Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review.
by: Murray, L, et al.
Published: (2017)

Correction: Application of four-dimensional cone beam computed tomography in lung cancer radiotherapy
by: Muyasha Abulimiti, et al.
Published: (2023-07-01)

Possibilities of Multispiral computed Tomography in the Diagnosis of Occlusive Diseases of the Biliary Tract
by: V. A. Malakhanov, et al.
Published: (2019-01-01)

Robotic Stereotactic Body Radiotherapy for Spine Metastasis Pain Relief
by: Rivas, D, et al.
Published: (2024)

Investigating the toxicity and safety of radiotherapy for pancreatic cancer
by: Holyoake, D
Published: (2018)

Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma
by: Yunfeng Li, et al.
Published: (2023-08-01)